Reboxetine: Additional benefits to the depressed patient

Journal of Psychopharmacology

Volumn 11, Issue 4 SUPPL., 1997, Pages

  Montgomery, Stuart A ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Depression; Desipramine; Efficacy; Fluoxetine; Imipramine; Noradrenaline reuptake inhibitor (NARI); Placebo; Reboxetine; Review; Social functioning

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; NORADRENALIN UPTAKE INHIBITOR; REBOXETINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; HUMAN; LONG TERM CARE; META ANALYSIS; MOTIVATION; PRIORITY JOURNAL; SELF CONCEPT; SOCIAL INTERACTION;

ADRENERGIC UPTAKE INHIBITORS; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; HUMANS; MORPHOLINES; NOREPINEPHRINE;

EID: 0030785126     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. Washington DC
2. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd rev edn. Washington DC
3. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. Washington DC
4. Angst J (1992) Epidemiology of depression. Psychopharmacol 102: S71-S74
5. Berzewski H, Van Moffaert M, Gagiano CA (1997) Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodes. Eur Neuropsychopharmacol 7 (Suppl. 1): S37-S47
6. Bosc M, Dubini A, Polin V (1997) Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur Neuropsychopharmacol 7 (Suppl. 1): S57-S70
7. Casey P (1993) Social function in psychiatry. Wrightson Biomedical Publishing Ltd
8. Clerc G E, Ruimy P, Verdeau Pailles J (1996) A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 9: 139-143
9. Committee for Proprietary Medicinal Products, European Economic Community (1994) Guidelines on psychotropic drugs for the EC. Eur Neuropsychopharmacol 4: 61-77
10. Danish University Antidepressant Group (DUAG) (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 30: 131-138
11. Danish University Antidepressant Group (1990) Paroxetine; a selective serotonin reuptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multi-center study. J Affect Dis 18: 289-299
12. Dubini A, Bosc M, Polin V (1997) Do noradrenaline and serotonin differentially affect social motivation and behaviour? Eur Neuropsychopharmacol 7 (Suppl. 1): S49-S55
13. Guy W (1976) ECDEU Assessment manual for psychopharmacology. US Department of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, Rockville, MD
14. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62
15. Healy D, McMonagle T (1997) The enhancement of social functioning as a therapeutic principle in the management of depression. J Psychopharmcol 11(Suppl.): S25-S31
16. Kessler R C, McGonagle K A, Zho S, Nelson C B, Hughes M, Eshleman S, Wittchen H U, Kendler K S (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8-19
17. Montgomery S A, Asberg M A (1979) New depression scale designed to be sensitive to change. BrJ Psychiatry 134: 382-389
18. Mucci M (1997) Reboxetine: a review of antidepressant tolerability. J Psychopharmcol 11(Suppl.): S33-S37
19. Nelson J C, Mazure C M, Bowers M B, Jatlow P I (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48: 303-307
20. Nelson J C, Mazure C M, Quinlan D M, Jatlow P I (1984) Drug-responsive symptoms in melancholia. Arch Gen Psychiatry 41: 663-668
21. Paykel E S, Weissman M M (1973). Social adjustment and depression. A longitudinal study. Arch Gen Psychiatry 28: 659-663
22. Schildkraut J J (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122: 509-522
23. Szabadi E, Bradshaw E M (1995) Affective disorders: I. Antidepressants. In: King D J (ed), Seminars in clinical psychopharmacology. Royal College of Psychiatrists/Gaskell, London, pp. 138-192
24. Van Den Berg S J (1995) Comparing SSRIs: from chemistry to clinical choice. Hum Psychopharmacol 10: S199-S209